Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium
Donato Cappetta, Antonella De Angelis, Loreta Pia Ciuffreda, Raffaele Coppini, Anna Cozzolino, Agostino Miccichè, Carmela Dell’Aversana, Domenico D’Amario, Eleonora Cianflone, Cristina Scavone, Lorenzo Santini, Chiara Palandri, Silvio Naviglio, Filippo Crea, Marcello Rota, Lucia Altucci, Francesco Rossi, Annalisa Capuano, Konrad Urbanek, Liberato Berrino
Topics & Concepts
DapagliflozinEndothelial dysfunctionMedicineInternal medicineEndotheliumCardiologyNitric oxideDiastoleCardioprotectionEjection fractionHeart failureHeart failure with preserved ejection fractionEndocrinologyDiabetes mellitusMyocardial infarctionBlood pressureType 2 diabetesDiabetes Treatment and ManagementPancreatic function and diabetesMetabolism, Diabetes, and Cancer